ASCT With Nivolumab in Patients With Multiple Myeloma
Clinical trial NCT03292263 · UNKNOWN
Trial details
- NCT number
- NCT03292263
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2024-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.